4 lessons for the pharma supply chain after COVID-19
The medical supply chain has proved remarkably resilient during the Covid-19 crisis with drug shortages kept to a minimum. However, the pandemic has exposed a weakness in global supply chains that have to address as the world economy recovers. How should companies prepare for the next global shock?
The post 4 lessons for the pharma supply chain after COVID-19 appeared first on OpenText Blogs.